These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9626172)

  • 1. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans.
    Lerman A; Burnett JC; Higano ST; McKinley LJ; Holmes DR
    Circulation; 1998 Jun; 97(21):2123-8. PubMed ID: 9626172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology.
    Drexler H; Fischell TA; Pinto FJ; Chenzbraun A; Botas J; Cooke JP; Alderman EL
    Circulation; 1994 Apr; 89(4):1615-23. PubMed ID: 8149529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis.
    Reriani M; Raichlin E; Prasad A; Mathew V; Pumper GM; Nelson RE; Lennon R; Rihal C; Lerman LO; Lerman A
    Circulation; 2010 Sep; 122(10):958-66. PubMed ID: 20733096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms.
    Egashira K; Hirooka Y; Kuga T; Mohri M; Takeshita A
    Circulation; 1996 Jul; 94(2):130-4. PubMed ID: 8674170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of vitamin E on L-arginine-responsive endothelial dysfunction in patients with mild hypercholesterolaemia and coronary artery disease.
    Chowienczyk PJ; Kneale BJ; Brett SE; Paganga G; Jenkins BS; Ritter JM
    Clin Sci (Lond); 1998 Feb; 94(2):129-34. PubMed ID: 9536920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine.
    Drexler H; Zeiher AM; Meinzer K; Just H
    Lancet; 1991 Dec 21-28; 338(8782-8783):1546-50. PubMed ID: 1683971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging-associated endothelial dysfunction in humans is reversed by L-arginine.
    Chauhan A; More RS; Mullins PA; Taylor G; Petch C; Schofield PM
    J Am Coll Cardiol; 1996 Dec; 28(7):1796-804. PubMed ID: 8962569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease.
    Adams MR; McCredie R; Jessup W; Robinson J; Sullivan D; Celermajer DS
    Atherosclerosis; 1997 Mar; 129(2):261-9. PubMed ID: 9105569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function.
    Wassmann S; Faul A; Hennen B; Scheller B; Böhm M; Nickenig G
    Circ Res; 2003 Oct; 93(9):e98-103. PubMed ID: 14551237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries.
    Dubois-Randé JL; Zelinsky R; Roudot F; Chabrier PE; Castaigne A; Geschwind H; Adnot S
    Am J Cardiol; 1992 Nov; 70(15):1269-75. PubMed ID: 1442577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass.
    Lucotti P; Monti L; Setola E; La Canna G; Castiglioni A; Rossodivita A; Pala MG; Formica F; Paolini G; Catapano AL; Bosi E; Alfieri O; Piatti P
    Metabolism; 2009 Sep; 58(9):1270-6. PubMed ID: 19592054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelium-dependent relaxation competes with alpha 1- and alpha 2-adrenergic constriction in the canine epicardial coronary microcirculation.
    Jones CJ; DeFily DV; Patterson JL; Chilian WM
    Circulation; 1993 Apr; 87(4):1264-74. PubMed ID: 8384938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of endothelium-dependent contraction of the canine coronary artery by UW solution.
    Lin PJ; Chang CH; Yao PC; Hsieh HC; Hsieh MJ; Kao CL; Tsai KT
    Transplantation; 1994 Dec; 58(12):1323-8. PubMed ID: 7809923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries.
    Yao SK; Ober JC; Krishnaswami A; Ferguson JJ; Anderson HV; Golino P; Buja LM; Willerson JT
    Circulation; 1992 Oct; 86(4):1302-9. PubMed ID: 1394936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-arginine infusion dilates coronary vasculature in patients undergoing coronary bypass surgery.
    Wallace AW; Ratcliffe MB; Galindez D; Kong JS
    Anesthesiology; 1999 Jun; 90(6):1577-86. PubMed ID: 10360855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats.
    Tschudi MR; Criscione L; Novosel D; Pfeiffer K; Lüscher TF
    Circulation; 1994 May; 89(5):2212-8. PubMed ID: 8181147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.
    Panza JA; Casino PR; Badar DM; Quyyumi AA
    Circulation; 1993 May; 87(5):1475-81. PubMed ID: 8491002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of actions of sumatriptan on coronary flow before and after endothelial dysfunction in guinea-pig isolated heart.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Mar; 120(6):1039-48. PubMed ID: 9134215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans.
    Lerman A; Holmes DR; Bell MR; Garratt KN; Nishimura RA; Burnett JC
    Circulation; 1995 Nov; 92(9):2426-31. PubMed ID: 7586341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.
    Chen JW; Hsu NW; Wu TC; Lin SJ; Chang MS
    Am J Cardiol; 2002 Nov; 90(9):974-82. PubMed ID: 12398965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.